Home
>
US Stocks
>
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
ENTA

Enanta Pharmaceuticals Inc

$71.4732.35%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
71.29
Today Low/High
70.85 / 72.16
52 Week Low/High
$40.32 / $56.97
P/E ratio
-11.5899
Market Cap
$970.51M

Company Details

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Enanta's research and development efforts have produced clinical candidates for the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH) and hepatitis B virus (HBV). Enanta is also conducting research in human metapneumovirus (hMPV) and emerging coronaviruses, including SARS-CoV-2.
Organisation
Enanta Pharmaceuticals Inc
Headquaters
Watertown, Massachusetts, US
Employees
141
Industry
Health Technology
CEO
Jay Luly

Discover more

Frequently Asked Questions

What is Enanta Pharmaceuticals Inc share price today

Can Indians buy Enanta Pharmaceuticals Inc shares?

How can I buy Enanta Pharmaceuticals Inc shares from India?

Can Fractional shares of Enanta Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Enanta Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor